Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats

Abstract.: To clarify the role of dipeptidyl peptidase-4 (DPP-4) inhibition in vascular tissues, we compared the effects of the poorly tissue-penetrative DPP-4 inhibitor sitagliptin to the highly tissue-penetrative DPP-4 inhibitor linagliptin in Zucker diabetic fatty (ZDF) rats. Six-week-old ZDF rat...

Full description

Bibliographic Details
Main Authors: Shinji Takai, Hiroshi Sakonjo, Denan Jin
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861319301082
_version_ 1819062581480914944
author Shinji Takai
Hiroshi Sakonjo
Denan Jin
author_facet Shinji Takai
Hiroshi Sakonjo
Denan Jin
author_sort Shinji Takai
collection DOAJ
description Abstract.: To clarify the role of dipeptidyl peptidase-4 (DPP-4) inhibition in vascular tissues, we compared the effects of the poorly tissue-penetrative DPP-4 inhibitor sitagliptin to the highly tissue-penetrative DPP-4 inhibitor linagliptin in Zucker diabetic fatty (ZDF) rats. Six-week-old ZDF rats were orally treated with placebo, sitagliptin (10 mg/kg), or linagliptin (3 mg/kg) for 4 weeks. Sitagliptin and linagliptin produced equivalent decreases in blood glucose concentrations and increased plasma insulin concentrations during oral glucose tolerance tests after the first and the last treatments. In isolated arteries, acetylcholine-induced vascular relaxation was significantly augmented by sitagliptin and linagliptin, with significantly stronger relaxation observed with linagliptin compared to sitagliptin. Vascular DPP-4 activity was attenuated by these drugs, with linagliptin producing significant greater attenuation than sitagliptin. Vascular malondialdehide levels were significantly lower with linagliptin compared to sitagliptin. Significantly greater attenuation of vascular gene expressions of p22phox and monocyte chemoattractant protein-1 by linagliptin, compared with sitagliptin, was also observed. In conclusion, the superior vascular protection by linagliptin compared with sitagliptin was unrelated to the regulation of circulating glucose and insulin levels, and the stronger vascular DPP-4 inhibition by linagliptin may contribute to the mechanism of vascular protection. Keywords:: diabetes, dipeptidyl peptidase 4, inhibitor, vascular tissue, penetration
first_indexed 2024-12-21T15:01:03Z
format Article
id doaj.art-30569bcc7b1246eba2047f51e1c0470a
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-12-21T15:01:03Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-30569bcc7b1246eba2047f51e1c0470a2022-12-21T18:59:35ZengElsevierJournal of Pharmacological Sciences1347-86132014-01-011254386393Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty RatsShinji Takai0Hiroshi Sakonjo1Denan Jin2Department of Pharmacology, Osaka Medical College, 2-7 Daigaku-cho, Takatsuki city, Osaka 569-8686, Japan; Corresponding author. pha010@art.osaka-med.ac.jpShiga Research Center, Nissei BILIS, 555 Minakuchi-cho, Shiga 528-0052, JapanDepartment of Pharmacology, Osaka Medical College, 2-7 Daigaku-cho, Takatsuki city, Osaka 569-8686, JapanAbstract.: To clarify the role of dipeptidyl peptidase-4 (DPP-4) inhibition in vascular tissues, we compared the effects of the poorly tissue-penetrative DPP-4 inhibitor sitagliptin to the highly tissue-penetrative DPP-4 inhibitor linagliptin in Zucker diabetic fatty (ZDF) rats. Six-week-old ZDF rats were orally treated with placebo, sitagliptin (10 mg/kg), or linagliptin (3 mg/kg) for 4 weeks. Sitagliptin and linagliptin produced equivalent decreases in blood glucose concentrations and increased plasma insulin concentrations during oral glucose tolerance tests after the first and the last treatments. In isolated arteries, acetylcholine-induced vascular relaxation was significantly augmented by sitagliptin and linagliptin, with significantly stronger relaxation observed with linagliptin compared to sitagliptin. Vascular DPP-4 activity was attenuated by these drugs, with linagliptin producing significant greater attenuation than sitagliptin. Vascular malondialdehide levels were significantly lower with linagliptin compared to sitagliptin. Significantly greater attenuation of vascular gene expressions of p22phox and monocyte chemoattractant protein-1 by linagliptin, compared with sitagliptin, was also observed. In conclusion, the superior vascular protection by linagliptin compared with sitagliptin was unrelated to the regulation of circulating glucose and insulin levels, and the stronger vascular DPP-4 inhibition by linagliptin may contribute to the mechanism of vascular protection. Keywords:: diabetes, dipeptidyl peptidase 4, inhibitor, vascular tissue, penetrationhttp://www.sciencedirect.com/science/article/pii/S1347861319301082
spellingShingle Shinji Takai
Hiroshi Sakonjo
Denan Jin
Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats
Journal of Pharmacological Sciences
title Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats
title_full Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats
title_fullStr Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats
title_full_unstemmed Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats
title_short Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats
title_sort significance of vascular dipeptidyl peptidase 4 inhibition on vascular protection in zucker diabetic fatty rats
url http://www.sciencedirect.com/science/article/pii/S1347861319301082
work_keys_str_mv AT shinjitakai significanceofvasculardipeptidylpeptidase4inhibitiononvascularprotectioninzuckerdiabeticfattyrats
AT hiroshisakonjo significanceofvasculardipeptidylpeptidase4inhibitiononvascularprotectioninzuckerdiabeticfattyrats
AT denanjin significanceofvasculardipeptidylpeptidase4inhibitiononvascularprotectioninzuckerdiabeticfattyrats